Biomarker characterization in endometrial cancer in Europe: first survey data analysis from 69 pathological academic and hospital labs-Reference-Cited by-同舟云学术

Biomarker characterization in endometrial cancer in Europe: first survey data analysis from 69 pathological academic and hospital labs

Published:2024-02 Issue:1 Volume:116 Page:32-45
ISSN:1591-951X
Container-title:Pathologica
language:
Short-container-title:Pathologica

Author:

Santoro Angela, ,Bragantini Emma,Castiglione Francesca,Ganesan Raji,Matias-Guiu Xavier,Frattini Milo,Gallotta Valerio,Garcia Pablo,Pattni Yatish,Tsiampali-Laprell Julia,Bisaro Brigitte,Barbareschi Mattia,Zannoni Gian Franco

Publisher

Siapec Servizi Srl

Reference29 articles.

1. Levine DA. Integrated genomic characterization of endometrial carcinoma. Nature. 2013;497:67-73. https://doi.org/10.1038/nature12113.

2. Talhouk A, McConechy MK, Leung S, et al. Confirmation of ProMisE: A simple, genomics-based clinical classifier for endometrial cancer. Cancer. 2017;123:802-13. https://doi.org/10.1002/cncr.30496.

3. Kommoss S, McConechy MK, Kommoss F, et al. Final validation of the ProMisE molecular classifier for endometrial carcinoma in a large population-based case series. Ann Oncol. 2018;29:1180-8. https://doi.org/10.1093/annonc/mdy058.

4. Stelloo E, Nout RA, Osse EM, et al. Improved Risk Assessment by Integrating Molecular and Clinicopathological Factors in Early-stage Endometrial Cancer-Combined Analysis of the PORTEC Cohorts. Clin Cancer Res. 2016;22:4215-24. https://doi.org/10.1158/1078-0432.CCR-15-2878.

5. Concin N, Creutzberg CL, Vergote I, et al. ESGO/ESTRO/ESP Guidelines for the management of patients with endometrial carcinoma. Virchows Arch. 2021;478:153-90. https://doi.org/10.1007/s00428-020-03007-z.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unsolved Issues in the Integrated Histo-Molecular Classification of Endometrial Carcinoma and Therapeutic Implications;Cancers;2024-07-04